These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6084823)

  • 1. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.
    Crow TJ; Cross AJ; Cooper SJ; Deakin JF; Ferrier IN; Johnson JA; Joseph MH; Owen F; Poulter M; Lofthouse R
    Neuropharmacology; 1984 Dec; 23(12B):1561-9. PubMed ID: 6084823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin receptor changes in dementia of the Alzheimer type.
    Cross AJ; Crow TJ; Ferrier IN; Johnson JA; Bloom SR; Corsellis JA
    J Neurochem; 1984 Dec; 43(6):1574-81. PubMed ID: 6208336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.
    Perry EK; Marshall E; Kerwin J; Smith CJ; Jabeen S; Cheng AV; Perry RH
    J Neurochem; 1990 Oct; 55(4):1454-6. PubMed ID: 1697897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical neurochemistry in Alzheimer-type dementia.
    Cross AJ; Crow TJ; Peters TJ
    Prog Brain Res; 1986; 70():153-69. PubMed ID: 3033741
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
    Bowen DM; Allen SJ; Benton JS; Goodhardt MJ; Haan EA; Palmer AM; Sims NR; Smith CC; Spillane JA; Esiri MM; Neary D; Snowdon JS; Wilcock GK; Davison AN
    J Neurochem; 1983 Jul; 41(1):266-72. PubMed ID: 6306169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and serotonergic receptors in suicide.
    Stanley M; Mann JJ; Cohen LS
    Ann N Y Acad Sci; 1986; 487():122-7. PubMed ID: 2436528
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
    Palmer AM; Wilcock GK; Esiri MM; Francis PT; Bowen DM
    Brain Res; 1987 Jan; 401(2):231-8. PubMed ID: 2434191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.
    Quirion R; Martel JC; Robitaille Y; Etienne P; Wood P; Nair NP; Gauthier S
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):503-10. PubMed ID: 2878714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laterality and 3H-imipramine binding: studies in the frontal cortex of normal controls and suicide victims.
    Arora RC; Meltzer HY
    Biol Psychiatry; 1991 May; 29(10):1016-22. PubMed ID: 1648414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5 HT2 receptors in dementia of Alzheimer type: a quantitative autoradiographic study of frontal cortex and hippocampus.
    Dewar D; Graham DI; McCulloch J
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):129-37. PubMed ID: 2222780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]ketanserin (serotonin type 2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid.
    Wenk GL; Engisch KL
    J Neurochem; 1986 Sep; 47(3):845-50. PubMed ID: 2942641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims.
    Arango V; Underwood MD; Boldrini M; Tamir H; Kassir SA; Hsiung S; Chen JJ; Mann JJ
    Neuropsychopharmacology; 2001 Dec; 25(6):892-903. PubMed ID: 11750182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia.
    Ichimiya Y; Arai H; Kosaka K; Iizuka R
    Acta Neuropathol; 1986; 70(2):112-6. PubMed ID: 3739621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced binding of [3H]ketanserin to cortical 5-ht2 receptors in senile dementia of the Alzheimer type.
    Reynolds GP; Arnold L; Rossor MN; Iversen LL; Mountjoy CQ; Roth M
    Neurosci Lett; 1984 Jan; 44(1):47-51. PubMed ID: 6717852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.
    Bowen DM; Najlerahim A; Procter AW; Francis PT; Murphy E
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9504-8. PubMed ID: 2574463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
    Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
    Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.
    Arai H; Kosaka K; Iizuka R
    J Neurochem; 1984 Aug; 43(2):388-93. PubMed ID: 6204013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropharmacological approach to major depression].
    Nakazawa K
    Yakubutsu Seishin Kodo; 1991 Apr; 11(2):171-6. PubMed ID: 1656650
    [No Abstract]   [Full Text] [Related]  

  • 20. Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.
    Bowen DM; Procter AW; Mann DM; Snowden JS; Esiri MM; Neary D; Francis PT
    Psychopharmacology (Berl); 2008 Mar; 196(4):603-10. PubMed ID: 18026720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.